PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China flag China · Delayed Price · Currency is CNY
40.01
-0.69 (-1.70%)
Apr 29, 2026, 3:04 PM CST

SHE:300725 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
375.61532.74290.2511.191,150699.63
Short-Term Investments
--618.48984.26303.46100.74
Trading Asset Securities
687.58735.57465.61105.35163.3304.43
Cash & Short-Term Investments
1,0631,2681,3741,6011,6171,105
Cash Growth
12.99%-7.71%-14.15%-1.01%46.38%-19.79%
Accounts Receivable
431.58386.03483.69473.66330.61201.27
Other Receivables
3.272.991.922.621.832.11
Receivables
434.86389.02485.61476.28332.44203.38
Inventory
655.42655.24840.17724.79676.39447.94
Other Current Assets
492.27363.1916.8815.8833.847.89
Total Current Assets
2,6462,6762,7172,8182,6601,804
Property, Plant & Equipment
1,6771,6531,6841,7531,6611,173
Long-Term Investments
1,3072,30319.865.485.668.91
Goodwill
355.74355.74355.74356.19356.19356.19
Other Intangible Assets
102.09103.59107.98109.42111.48111.47
Long-Term Deferred Tax Assets
39.1239.8232.6338.6135.815.1
Long-Term Deferred Charges
14.8110.136.9410.149.187.24
Other Long-Term Assets
248.34198.310.9913.122.830.74
Total Assets
6,3907,3404,9355,1044,8623,507
Accounts Payable
354.09312.75292.2278.7413.47267.35
Accrued Expenses
55.0595.5491104.7188.1860.61
Short-Term Debt
100.06100.06230.27236.5163.4347.64
Current Portion of Long-Term Debt
4.734.7552.74371.4317.297.95
Current Portion of Leases
--1.261.99-1.82
Current Income Taxes Payable
25.0232.4516.9615.70.850.15
Current Unearned Revenue
77.9170.0956.2832.7339.6328.7
Other Current Liabilities
8.286.188.5314.3316.3574.66
Total Current Liabilities
625.13621.82749.231,056739.18788.88
Long-Term Debt
--1,1271,1381,39223.6
Long-Term Leases
7.647.873.210.23--
Long-Term Unearned Revenue
43.1244.846.6152.6452.8554.14
Long-Term Deferred Tax Liabilities
215.19365.2522.1324.3120.1512.58
Total Liabilities
891.081,0401,9482,2722,205879.21
Common Stock
233.81233.81199.73199.66199.66199.7
Additional Paid-In Capital
2,3382,3381,0961,0901,0751,299
Retained Earnings
1,8731,8241,5971,4391,261967.1
Treasury Stock
-30.04-30.04-30.04-20.03--35
Comprehensive Income & Other
1,0851,935125.24123.52121.74-3.44
Total Common Equity
5,4996,3002,9882,8322,6582,427
Minority Interest
----0200.29
Shareholders' Equity
5,4996,3002,9882,8322,6582,628
Total Liabilities & Equity
6,3907,3404,9355,1044,8623,507
Total Debt
112.42112.671,4141,7491,573381.02
Net Cash (Debt)
950.771,156-39.71-147.8344.11723.78
Net Cash Growth
-----93.91%-42.42%
Net Cash Per Share
4.385.53-0.20-0.730.223.63
Filing Date Shares Outstanding
232.79231.48198.89198.83199.66199.7
Total Common Shares Outstanding
232.79231.48198.89198.83199.66199.7
Working Capital
2,0212,0541,9681,7621,9211,015
Book Value Per Share
23.6227.2215.0214.2413.3112.16
Tangible Book Value
5,0415,8412,5242,3672,1901,960
Tangible Book Value Per Share
21.6525.2312.6911.9010.979.81
Buildings
--950.4905.31844.6344.88
Machinery
--1,0521,025792.72510.13
Construction In Progress
--232.68256.23357.53575.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.